• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

额颞叶痴呆中的抗核抗体:自身免疫冰山的一角?

Antinuclear antibodies in Frontotemporal Dementia: the tip's of autoimmunity iceberg?

机构信息

Rheumatology and Clinical Immunology, Spedali Civili Hospital, Brescia, Italy.

Neurology Unit, Centre for Neurodegenerative Disorders, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

出版信息

J Neuroimmunol. 2018 Dec 15;325:61-63. doi: 10.1016/j.jneuroim.2018.10.006. Epub 2018 Oct 19.

DOI:10.1016/j.jneuroim.2018.10.006
PMID:30391902
Abstract

Recent studies suggest a role of the autoimmune system dysregulation in Frontotemporal dementia (FTD). In the present study, we performed a broad immunological screening in a large sample of sporadic FTD patients. We reported a significant increase of antinuclear autoantibodies (ANA) positivity in 100 FTD patients as compared to 100 healthy controls (HC) (60% vs. 13%, p < .001). In FTD, ANA-positive and ANA-negative patients did not differ for any clinical feature. These data extend and further confirm autoimmune dysregulation in FTD. However, it still remains to be clarified whether these antibodies have a potential pathogenic role or represent simply an epiphenomenon.

摘要

最近的研究表明,自身免疫系统失调在额颞叶痴呆(FTD)中起作用。在本研究中,我们对大量散发性 FTD 患者进行了广泛的免疫学筛查。与 100 名健康对照组(HC)相比,我们报告了 100 名 FTD 患者的抗核自身抗体(ANA)阳性率显著增加(60% vs. 13%,p <.001)。在 FTD 中,ANA 阳性和 ANA 阴性患者在任何临床特征方面均无差异。这些数据扩展并进一步证实了 FTD 中的自身免疫失调。然而,这些抗体是否具有潜在的致病作用,或者仅仅是一种伴随现象,仍有待阐明。

相似文献

1
Antinuclear antibodies in Frontotemporal Dementia: the tip's of autoimmunity iceberg?额颞叶痴呆中的抗核抗体:自身免疫冰山的一角?
J Neuroimmunol. 2018 Dec 15;325:61-63. doi: 10.1016/j.jneuroim.2018.10.006. Epub 2018 Oct 19.
2
Antinuclear autoantibodies in chronic schizophrenia.慢性精神分裂症中的抗核自身抗体。
Acta Psychiatr Scand. 1995 Oct;92(4):266-9. doi: 10.1111/j.1600-0447.1995.tb09581.x.
3
Anti-AMPA GluA3 antibodies in Frontotemporal dementia: a new molecular target.抗 AMPA 型谷氨酸受体 GluA3 抗体在额颞叶痴呆中的作用:一个新的分子靶点。
Sci Rep. 2017 Jul 27;7(1):6723. doi: 10.1038/s41598-017-06117-y.
4
Anti-GluA3 antibodies in frontotemporal dementia: effects on glutamatergic neurotransmission and synaptic failure.抗 GluA3 抗体在额颞叶痴呆中的作用:对谷氨酸能神经传递和突触衰竭的影响。
Neurobiol Aging. 2020 Feb;86:143-155. doi: 10.1016/j.neurobiolaging.2019.10.015. Epub 2019 Nov 1.
5
Clinical significance of elevated antinuclear antibodies in patients with diffuse large B-cell lymphoma: A single center study.弥漫性大B细胞淋巴瘤患者抗核抗体升高的临床意义:一项单中心研究。
J Cancer Res Ther. 2018 Jan;14(1):213-219. doi: 10.4103/0973-1482.183559.
6
Autoantibody-Positive Healthy Individuals Display Unique Immune Profiles That May Regulate Autoimmunity.自身抗体阳性的健康个体表现出独特的免疫谱,可能调节自身免疫。
Arthritis Rheumatol. 2016 Oct;68(10):2492-502. doi: 10.1002/art.39706.
7
Autoimmunity and Frontotemporal Dementia.自身免疫与额颞叶痴呆
Curr Alzheimer Res. 2018;15(7):602-609. doi: 10.2174/1567205015666180119104825.
8
[Detection and the production mechanism of antinuclear antibodies (ANA) and anti-liver/kidney microsomal tpe 1 antibodies (anti-LKM1) in patients with chronic hepatitis C].[丙型肝炎患者抗核抗体(ANA)及抗肝肾微粒体1型抗体(抗-LKM1)的检测及其产生机制]
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2009 Aug;23(4):278-81.
9
[Investigation of antinuclear antibodies in chronic hepatitis B patients].[慢性乙型肝炎患者抗核抗体的研究]
Mikrobiyol Bul. 2018 Oct;52(4):425-430. doi: 10.5578/mb.67262.
10
Antinuclear antibody positivity in patients with chronic hepatitis C: clinically relevant or an epiphenomenon?慢性丙型肝炎患者的抗核抗体阳性:有临床意义还是一种伴随现象?
Eur J Gastroenterol Hepatol. 2009 Apr;21(4):350-6. doi: 10.1097/MEG.0b013e3283089392.

引用本文的文献

1
Immunological Fluid Biomarkers in Frontotemporal Dementia: A Systematic Review.额颞叶痴呆的免疫体液生物标志物:一项系统评价。
Biomolecules. 2025 Mar 24;15(4):473. doi: 10.3390/biom15040473.
2
Brain-targeting autoantibodies in patients with dementia.痴呆症患者的脑靶向自身抗体。
Front Neurol. 2024 Jul 10;15:1412813. doi: 10.3389/fneur.2024.1412813. eCollection 2024.
3
Anti-NMDA and Anti-AMPA Receptor Antibodies in Central Disorders: Preclinical Approaches to Assess Their Pathological Role and Translatability to Clinic.
中枢神经系统疾病中的抗 NMDA 和抗 AMPA 受体抗体:评估其病理性作用及向临床转化的转化医学研究方法。
Int J Mol Sci. 2023 Oct 5;24(19):14905. doi: 10.3390/ijms241914905.
4
Autoimmunity and Frontotemporal Lobar Degeneration: From Laboratory Study to Clinical Practice.自身免疫与额颞叶变性:从实验室研究到临床实践。
Clin Interv Aging. 2023 Mar 27;18:495-503. doi: 10.2147/CIA.S394286. eCollection 2023.
5
Glycoprotein Pathways Altered in Frontotemporal Dementia With Autoimmune Disease.免疫性疾病相关额颞叶痴呆中糖蛋白通路的改变。
Front Immunol. 2021 Sep 1;12:736260. doi: 10.3389/fimmu.2021.736260. eCollection 2021.
6
NMDA and AMPA Receptor Autoantibodies in Brain Disorders: From Molecular Mechanisms to Clinical Features.脑疾病中的 NMDA 和 AMPA 受体自身抗体:从分子机制到临床特征。
Cells. 2021 Jan 5;10(1):77. doi: 10.3390/cells10010077.
7
Peripheral inflammatory markers and clinical correlations in patients with frontotemporal lobar degeneration with and without the C9orf72 repeat expansion.伴有和不伴有 C9orf72 重复扩展的额颞叶变性患者的外周炎症标志物及临床相关性。
J Neurol. 2020 Jan;267(1):76-86. doi: 10.1007/s00415-019-09552-1. Epub 2019 Sep 26.
8
Prodromal and Early bvFTD: Evaluating Clinical Features and Current Biomarkers.前驱期和早期行为变异型额颞叶痴呆:评估临床特征和当前生物标志物
Front Neurosci. 2019 Jun 21;13:658. doi: 10.3389/fnins.2019.00658. eCollection 2019.
9
Toward a Glutamate Hypothesis of Frontotemporal Dementia.走向额颞叶痴呆的谷氨酸假说。
Front Neurosci. 2019 Mar 29;13:304. doi: 10.3389/fnins.2019.00304. eCollection 2019.